Tarsus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $71.55 |
Previous Close | $71.92 |
Day Range | $71-$71.98 |
52W Range | $48.20-$85.25 |
Market Cap | $3.1B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $606.3M |
Revenue Growth (YoY) | 69.4% |
Gross Profit (12 Mos) | $501.2M |
Diluted EPS | -$1.07 |
News
See moreYahoo Finance • 2 days ago
Tarsus acquisition of Alkeus granted FTC early termination
Yahoo Finance • 22 days ago
Tarsus Pharmaceuticals To Acquire Alkeus Pharmaceuticals
Yahoo Finance • 2 months ago
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline
Yahoo Finance • 2 months ago
Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 17700 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 370 |